Form 4: Labcorp EVP, CHRO Anita Z. Graham Reports Stock Transactions

Anita Z. Graham, EVP, CHRO of Labcorp Holdings Inc., reports the vesting and disposal of restricted stock units to cover tax obligations.

Summary

• On February 6, 2025, Anita Z. Graham, EVP, CHRO of Labcorp Holdings Inc., vested 326 restricted stock units and disposed of 618 common stock.
• Also on February 6, 2025, 118 shares were withheld to satisfy tax obligations at a price of $247.74.
• On February 7, 2025, Graham vested 369 restricted stock units and disposed of 869 common stock.
• Additionally on February 7, 2025, 119 shares were withheld to satisfy tax obligations at a price of $246.27.
• Following these transactions, Graham directly owns 500 shares of common stock and 750 shares of common stock.
• Graham also holds 1,390 and 1,021 restricted stock units respectively.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
• The transactions reported are typical for executives who receive stock-based compensation, such as restricted stock units.
• Similar filings can be observed across the healthcare and diagnostics industry for companies like Quest Diagnostics (DGX) and Bio-Rad Laboratories (BIO).

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership of shares.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Labcorp Holdings Inc., Anita Z. Graham, Restricted Stock Units, Common Stock, Form 4, EVP, CHRO, Vesting, Tax Withholding